Skip to content

Transcutaneous Auricular Vagus Nerve Stimulation for Early Gastrointestinal Rehabilitation Post-Laparoscopic Colorectal Cancer Surgery

Transcutaneous Auricular Vagus Nerve Stimulation for Early Gastrointestinal Rehabilitation Post-Laparoscopic Colorectal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113635
Enrollment
Unknown
Registered
2025-12-01
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Laparoscopic Colorectal Cancer Surgery

Interventions

Sham taVNS group:Perioperative management of colorectal cancer+sham taVNS
taVNS group:Perioperative management of colorectal cancer+taVNS

Sponsors

Nanjing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-85 years, no restriction on gender; 2. Patients scheduled for elective laparoscopic radical resection of colorectal cancer with primary anastomosis; 3. Newly diagnosed patients (defined as: first confirmed diagnosis of colorectal cancer, no prior tumor-related treatment before surgery, including neoadjuvant chemotherapy, neoadjuvant radiotherapy, targeted therapy, or immunotherapy); 4. Undergoing abdominal surgery for the first time; 5. General anesthesia, meeting American Society of Anesthesiologists (ASA) classification I-III; 6. Auricular skin intact, without damage, inflammation, eczema, or scars; 7. Elderly subjects aged 65-85 must complete the Mini-Mental State Examination (MMSE) screening, with a score >=20.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, kidney dysfunction, or mental illness; 2. Patients undergoing palliative surgery or emergency surgery; 3. Patients requiring combined resection of other organs; 4. Patients who experience serious complications during surgery (anastomotic leakage, gastrointestinal bleeding); 5. Patients whose laparoscopic surgery fails and require conversion to open surgery; 6. Patients with external stomas; 7. Patients with implanted electronic devices such as pacemakers or insulin pumps; 8. Pregnant or breastfeeding women; 9. Patients simultaneously participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Achievement rate of GI-3 within 72 hours after surgery;

Secondary

MeasureTime frame
Time to first postoperative anal flatus;Time to first postoperative defecation;Time to postoperative bowel sound appearance;Time to normalization of postoperative bowel sounds;Time to first postoperative water intake;Time to tolerance of postoperative liquid diet;Time to tolerance of postoperative solid diet;Time to first postoperative ambulation;Postoperative length of hospital stay;Time to initiation of independent postoperative ambulation;Number of episodes of nausea, vomiting, and bloating;Severity of postoperative pain;

Countries

China

Contacts

Public ContactZhang Yang

Nanjing Hospital of Traditional Chinese Medicine

21670235@qq.com+86 131 8283 5012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026